thrombotic disorders Flashcards

1
Q

virchows triad - risk factors for thrombosis

A

vascular injury

  • atheroscerlosis
  • trauma
  • surgical manipulation
  • prior thrombosis

stasis

  • immobility
  • pressure
  • increased viscosity

hyper coagulability

  • increased procoagulants
  • decreased inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe deep vein thrombosis and its presentation

A

thrombosis of left veins

leg swelling, pitting oedema, leg pain
venous discolouration

often clot can break off and cause emboli (PE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

signs and symptoms of pulmonary embolism

A

symptoms

  • chest pain
  • SOB
  • blood in cough

signs

  • tachycardia
  • tachypnoea
  • hypoxia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

testing for PE

A

D-dimer

CT pulmonary angiogram performed

V/Q scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

define D-dimer

A

measure the products of fibrin breakdown

  • positive in DVT and PE
  • also positive with inflammation, surgery etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

define thrombophilia

A
  • tendency to develop thrombosis
  • acquired and/or inherited
  • manifests as VTE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

causes of VTE

A
1/3 = spontaneous
2/3 = provoked events
 - surgery, trauma
 - immobility, hospitalisation
 - malignancy
 - HRT, COCP, pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

inherited thrombophilia

A

abnormal inhibitor function

  • resistant to activated protein C
  • due to mutant factor V Leiden

deficiency of inhibitors
- antithrombin, protein C and S

increased factor levels

  • prothrombin gene mutation
  • elevated factor VIII
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

factor V leiden

A

normal coagulation factor Va is inactivated by protein C

factor V leiden is the mutation form and as a result can’t be inactivated by protein C so continues

leading to increased risk of venous thrombosis

single point mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

thrombophilia testing

A
  • measuring factor V leiden and prothrombin gene mutation
  • also measure natural inhibitors
    more sever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

number 1 treatment for VTE

A

LMWH and warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

heparin

A
  • increases antithrombin effect (inhibits thrombin)
  • given initially, immediate effect
  • prolongs APTT however this can be reversed with protamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

LMWH effect

A

increases antithrombin effect (inhibits Xa)

subcutaneous with better bioavailability

doesn’t cause significant APTT or TCT prolong

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

warfarin

A
  • monitor with INR
  • interaction with many drugs
  • lag between starting drug and effect, due to vitamin K stores
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

positives and negatives of direct acting oral anticoagulants

A

positives

  • no monitoring required
  • fixed dose
  • less intracranial haemorrhage (compared to warfarin)

negatives
- kidney excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

dabigatran

A

DOAC

  • inhibits IIa (thrombin)
  • TCT extremely sensitive
  • APTT prolonged
17
Q

dabigatran antidote

A

= idarucrizumab

18
Q

direct acting oral anticoagulants

A

direct inhibitors of activated clotting factors